Trial intelligence / Profile preview

Growth Hormone in Infants with CRI

NCT00184769Phase 4Completed

Sponsor
Novo Nordisk
Start
Jan 1998
Primary completion
Dec 2005
Modality
Hormone, rProtein (Recombinant Protein), Biologic
Countries
2
01

Overview

A Phase 4 trial of somatropin, sponsored by Novo Nordisk. Started Jan 1998; status: completed.

02

Drugs

somatropin

Beyond the preview

Go deeper on NCT00184769.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00184769.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call